Keratocan, a cornea-specific keratan sulfate proteoglycan, is regulated by lumican
about
Stem cell therapy restores transparency to defective murine corneasRegulation of corneal stroma extracellular matrix assemblyFocus on molecules: lumicanHuman primary corneal fibroblasts synthesize and deposit proteoglycans in long-term 3-D cultures.Lumican binds ALK5 to promote epithelium wound healingCell therapy of congenital corneal diseases with umbilical mesenchymal stem cells: lumican null miceSphere-forming cells from peripheral cornea demonstrate the ability to repopulate the ocular surfaceDifferential cerebral cortex transcriptomes of baboon neonates consuming moderate and high docosahexaenoic acid formulas.A novel protocol of whole mount electro-immunofluorescence stainingInterclass small leucine-rich repeat proteoglycan interactions regulate collagen fibrillogenesis and corneal stromal assembly.Efficacious and safe tissue-selective controlled gene therapy approaches for the cornea.Regulation of corneal inflammation by neutrophil-dependent cleavage of keratan sulfate proteoglycans as a model for breakdown of the chemokine gradient.Cornea lenticule viability and structural integrity after refractive lenticule extraction (ReLEx) and cryopreservation.Transforming growth factor β and insulin signal changes in stromal fibroblasts of individual keratoconus patientsA comparison of glycosaminoglycan distributions, keratan sulphate sulphation patterns and collagen fibril architecture from central to peripheral regions of the bovine corneaEffects of ultraviolet-A and riboflavin on the interaction of collagen and proteoglycans during corneal cross-linking.Matrix morphogenesis in cornea is mediated by the modification of keratan sulfate by GlcNAc 6-O-sulfotransferase.Posterior amorphous corneal dystrophy is associated with a deletion of small leucine-rich proteoglycans on chromosome 12Proteome profiling of wild type and lumican-deficient mouse corneas.Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy.Pathophysiological mechanisms of autosomal dominant congenital stromal corneal dystrophy: C-terminal-truncated decorin results in abnormal matrix assembly and altered expression of small leucine-rich proteoglycansFibroblast growth factor receptor 2 (FGFR2) is required for corneal epithelial cell proliferation and differentiation during embryonic developmentThe P2X(7) receptor regulates proteoglycan expression in the corneal stromaExpression Profiles of Neuropeptides, Neurotransmitters, and Their Receptors in Human Keratocytes In Vitro and In Situ.Enlargement of the Axial Length and Altered Ultrastructural Features of the Sclera in a Mutant Lumican Transgenic Mouse Model.Resistance of corneal RFUVA–cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases.Derivation of Corneal Keratocyte-Like Cells from Human Induced Pluripotent Stem CellsCorneal stromal stem cells reduce corneal scarring by mediating neutrophil infiltration after wounding.Differential expression of epithelial basement membrane components nidogens and perlecan in corneal stromal cells in vitro.Keratocyte phenotype is enhanced in the absence of attachment to the substratumGenetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycanPrelude to corneal tissue engineering - gaining control of collagen organization.Transplantation of human umbilical mesenchymal stem cells cures the corneal defects of mucopolysaccharidosis VII mice.Keratocan and lumican regulate neutrophil infiltration and corneal clarity in lipopolysaccharide-induced keratitis by direct interaction with CXCL1.The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly.Supra-molecular assembly of a lumican-derived peptide amphiphile enhances its collagen-stimulating activity.Corneal stromal stem cells versus corneal fibroblasts in generating structurally appropriate corneal stromal tissue.Cell Therapy of Corneal Diseases.Sphere formation from corneal keratocytes and phenotype specific markersLoss of osteopontin perturbs the epithelial-mesenchymal transition in an injured mouse lens epithelium.
P2860
Q24605272-140F8411-4B4E-4EF1-83E9-8EA401F2F4F4Q26830340-B4CD0B34-EEBC-4987-8B09-8B0658862C9EQ28276208-D16FEA68-A8A3-4F87-9E4E-AB476A13EC4FQ28287055-2FB5928F-1067-4089-AF60-78EAE930CB55Q28537729-253DD420-E4AF-4C10-BDE9-D9C84F893BE6Q28752048-115450DB-DA0D-45C6-B7AA-5B3AFE4293BEQ28829595-0394D4B2-3ED8-4C34-8747-C825A08F71A3Q33281757-6AC7F2E6-17F6-46F1-80FE-161D059C03B0Q33415045-76284FDB-3809-4AC0-9C51-3B526477C00EQ33690533-43B3CF5D-CC92-4EEF-BB04-54B17C51F2BDQ33886878-23EA5860-2D45-459B-8857-7CD1659B9608Q34076118-C18B4B0E-6DAC-4B08-8F72-84E7C44A326BQ34118957-ABEFA211-AE9F-4544-8FB5-592C43E99E66Q34231516-9E281464-D10F-4B43-B1EB-2B5C783412BEQ34348778-1D37BDF4-ABA7-4193-BFC4-8662ACA72BC9Q34787055-9E9D41B1-3A95-4E37-B7CD-6DC13B91009AQ35037223-41C90D39-D15C-44BF-92E5-8F1C0E39603FQ35156016-33D9C441-C577-4002-97C2-D5C09F699D98Q35186369-603A3B11-6F89-48CE-9CC8-5CB1EC8D72B0Q35220955-79F98D0E-C79D-49A4-97B0-B2378E0CBC13Q35475232-8D07A94D-BF66-45A4-AC19-1B55AB6DDD74Q35548009-4B6B5AF6-86DC-4E0F-B772-8339D45DF459Q35691962-9630E7E7-781A-4F7E-9832-1BAFDA4B6C2CQ35716531-CA1E55CF-5F09-4302-9143-C2FC85718927Q36155357-EF8A1D5A-E0C7-41BB-9133-C61D0C6D31C6Q36159535-97B9272E-90E5-4507-95C8-7AF62032B16BQ36177320-C22C6D6B-0D08-40EB-BB10-21C7342893B9Q36296551-E9C3CF30-8DCD-4485-94D8-782E3CCDDE97Q36440543-320B2FC2-F76E-4869-A6B4-BE16578BB44CQ36479031-02C9887F-8BDD-4373-9EC5-CD147B5764B1Q37136836-49DF7F62-36B1-446C-B23A-4A0C32FDA2E1Q37262575-C6BC65AC-E714-4221-815E-FCE38ACA6601Q37265970-66AE1285-965B-4A6F-8A7E-033726ABE766Q37539974-537D7149-1DD7-45A0-8DD8-BD161B91D780Q38075193-7FFEEB1E-1449-4923-B69D-94DC0B05427BQ38270418-43718AB0-9986-4A7D-A7E7-4F817A29E7A1Q38655580-32BB5ADC-E185-470A-864A-4AA541857446Q38955068-453A0505-CCED-44AB-8D73-73B6DD2C3911Q39425169-D8B99314-71E5-4EB1-ABAA-89DB52881246Q40185259-02E28592-868E-40A5-BBDA-14077B5C9463
P2860
Keratocan, a cornea-specific keratan sulfate proteoglycan, is regulated by lumican
description
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2005
@ast
im Juli 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/07/08)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/07/08)
@nl
наукова стаття, опублікована в липні 2005
@uk
name
Keratocan, a cornea-specific keratan sulfate proteoglycan, is regulated by lumican
@ast
Keratocan, a cornea-specific keratan sulfate proteoglycan, is regulated by lumican
@en
Keratocan, a cornea-specific keratan sulfate proteoglycan, is regulated by lumican
@nl
type
label
Keratocan, a cornea-specific keratan sulfate proteoglycan, is regulated by lumican
@ast
Keratocan, a cornea-specific keratan sulfate proteoglycan, is regulated by lumican
@en
Keratocan, a cornea-specific keratan sulfate proteoglycan, is regulated by lumican
@nl
prefLabel
Keratocan, a cornea-specific keratan sulfate proteoglycan, is regulated by lumican
@ast
Keratocan, a cornea-specific keratan sulfate proteoglycan, is regulated by lumican
@en
Keratocan, a cornea-specific keratan sulfate proteoglycan, is regulated by lumican
@nl
P2093
P2860
P3181
P356
P1476
Keratocan, a cornea-specific keratan sulfate proteoglycan, is regulated by lumican
@en
P2093
Candace W.-C. Kao
Chia-Yang Liu
David E. Birk
Eric C. Carlson
James L. Funderburgh
James V. Jester
Tai-ichiro Chikama
Winston W.-Y. Kao
Yasuhito Hayashi
P2860
P304
25541–25547
P3181
P356
10.1074/JBC.M500249200
P407
P577
2005-07-08T00:00:00Z